Fund moves

Labcorp (LH): Select Equity Group, L.P. reduced its stake -193K shares

Select Equity Group, L.P. reduced its stake in Labcorp, per its Q2 2026 13F.

1.98M
Shares reported · -193K vs prior quarter
2.7%
Disclosed portfolio weight
$555M
Reported value
Holdings as of
Jun 30, 2026
Filed
Aug 14, 2026

What stands out in this filing

  • 2,174,785 shares in Q1 2026, 1,981,948 now (−8.9% in share count).
  • Reported at $555M, 2.74% of the portfolio value in this 13F filing.
  • 37 other tracked managers reported the same kind of change for Q2 2026.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

The company's last weighty Form 8-K report up to this date: changed a top executive or board member, 3 days earlier (Aug 11, 2026). The first one after it: reported its results, 75 days later (Oct 28, 2026).

  1. CongressDisclosed purchase of LH — reported range $1,001 - $15,000
  2. Insider · 2 peopleInsiders: 2 sales (~$93K)
  3. Company filing · Form 8-K · ResultsReported its results
  4. Insider · 1 personInsiders: 2 sales (~$439K)
  5. InsiderOfficer sold ~$283K of LH shares in the open market
  6. CongressDisclosed partial sale of LH — reported range $1,001 - $15,000
  7. CongressDisclosed partial sale of LH — reported range $1,001 - $15,000
  8. CongressDisclosed partial sale of LH — reported range $1,001 - $15,000
  9. Company filing · Form 8-K · Executive changeChanged a top executive or board member“On August 11, 2026, Megan D. Bailey notified Labcorp Holdings Inc. (the “Company”) of her decision to resign as Executive Vice President and President, Central Laboratories and International of the Company, effective September 4, 2026.”
  10. InsiderCEO sold ~$1.5M of LH shares in the open market

What came next

  1. InsiderDirector sold ~$954K of LH shares in the open market
  2. CongressDisclosed sale of LH — reported range $100,001 - $250,000
  3. Company filing · Form 8-K · ResultsReported its results
  4. InsiderDirector sold ~$389K of LH shares in the open market
  5. InsiderOfficer sold ~$108K of LH shares in the open market
  6. InsiderOfficer sold ~$744K of LH shares in the open market
  7. InsiderOfficer sold ~$136K of LH shares in the open market
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Labcorp

For Labcorp, OQRO holds 9 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LH page.

How this filing works

Explore the data

Common questions

What does this filing report about Labcorp (LH) stock?

Select Equity Group, L.P. reduced its stake in Labcorp, per its Q2 2026 13F. Now 1.98M shares, $555M reported value, 2.7% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Jun 30, 2026. Filed: Aug 14, 2026.

What stands out in this filing?

2,174,785 shares in Q1 2026, 1,981,948 now (−8.9% in share count). Reported at $555M, 2.74% of the portfolio value in this 13F filing. 37 other tracked managers reported the same kind of change for Q2 2026.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Labcorp recently?

For Labcorp, OQRO holds 9 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the LH page.

Does this mean LH stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Labcorp

Everything OQRO holds on this company is on its LH page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data